Proteome Sciences discovers 200 biomarkers for allergy testing; OECD issues biomarkers recommendations;

> As part of the Sens-it-iv project, Proteome Sciences has discovered more than 200 biomarkers and developed 8 assays to test chemicals, pharmaceuticals, cosmetics and detergents for skin and respiratory allergies. Press release

> The OECD has published a report on the "Policy Issues for the Development and Use of Biomarkers in Health," which aimed to review the current economic, regulatory, and healthcare context of the development of biomarkers, and identify the barriers to uptake. Abstract | Article

> OracleBio to provide Redx Pharma with biomarker services for preclinical R&D programs. Press release

> The annual Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia meeting has identified candidate imaging biomarkers for executive control in schizophrenia. Abstract

> Urinary FSP1 could be used as a biomarker for kidney damage. Abstract

> A multiparameter MRI may have potential as a biomarker in decisions for acute treatment of stroke. Abstract

> Changes in cell junction staining indicate thyroid cancer. Abstract

> Abbott ($ABT) and GSK ($GSK) have expanded their companion diagnostic agreement to include lung cancer diagnostic. Press release

> An inflammation biomarker has been associated with rebleeding in stroke. Abstract

> HealthLinx signs up Oryzon Genomics as exclusive distributor of OvPlex ovarian cancer diagnostics in Spain. News

> Metabolomics could lead to discovery of clinically useful biomarkers. Abstract

> Mass spectrometry is being used to find infection biomarkers. Abstract

> The proteome and metabolome could be potential sources for cancer biomarker discovery. Abstract

> Calreticulin could have potential as a predictive and diagnostic biomarker for lung cancer. Abstract

> Urinary F2-isoprostanes could indicate low risk of Type 2 diabetes. Abstract

And Finally... Joyce Licht Sang of the Ryan Licht Sang Bipolar Foundation was honored as Woman of Distinction for her foundation's work including research into a bipolar disease biomarker. Article

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.